Protective Effect of Antiasthma Drugs on Late Asthmatic Reactions and Increased Airway Responsiveness Induced by Toluene Diisocyanate in Sensitized Subjects
- 1 December 1987
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 136 (6) , 1403-1407
- https://doi.org/10.1164/ajrccm/136.6.1403
Abstract
To determine whether 4 drugs used in the treatment of asthma inhibit the late asthmatic reaction and the associated increase in airway responsiveness induced by toluene diisocyanate (TDI), we studied 24 sensitized subjects divided into 4 groups. Beclomethasone aerosol (1 mg bid), slow-release theophylline (6.5 mg/kg bid), slow-release verapamil (120 mg bid), and cromolyn (20 mg qid via sphinhaler), were administered for 7 days, respectively, to 1 of the 4 groups, according to a double-blind, crossover, placebo-controlled study design. When the subjects were treated with placebo, verapamil, or cromolyn, FEV1 markedly decreased and airway responsiveness increased after exposure to TDI. By contrast, beclomethasone prevented the late asthmatic reaction and the associated increase in airway responsiveness to methacholine induced by TDI. Slow-release theophylline partially inhibited both the immediate and the late asthmatic reactions but had no effect on airway hyperresponsiveness to methacholine. These results suggest that only high-dose inhaled steroids can completely block TDI-induced late asthmatic reactions.This publication has 3 references indexed in Scilit:
- Atropine Does not Inhibit Late Asthmatic Responses Induced by Toluene-Diisocyanate in Sensitized SubjectsAmerican Review of Respiratory Disease, 1987
- Time course of the increase in airway responsiveness associated with late asthmatic reactions to toluene diisocyanate in sensitized subjectsJournal of Allergy and Clinical Immunology, 1985
- Toluene diisocyanate pulmonary disease: Immunopharmacologic and mecholyl challenge studiesJournal of Allergy and Clinical Immunology, 1977